Alterity Therapeutics Liabilities 2024

Alterity Therapeutics Aktienanalyse

What does Alterity Therapeutics do?

Alterity Therapeutics Ltd is an Australian company specializing in the discovery and development of therapeutics for neurodegenerative diseases. The company's history dates back to 1997 when it was established under the name Prana Biotechnology Limited. Alterity Therapeutics' business model is based on the research of protein aggregates responsible for neurodegenerative diseases. The company primarily focuses on developing drugs targeting the breakdown of these protein aggregates to minimize the effects of diseases such as Parkinson's, Alzheimer's, and Huntington's. The company has several divisions specializing in various aspects of product development, including preclinical research, clinical development, and commercial marketing. Alterity Therapeutics has several products in various stages of development. One of its leading products is PBT434, a drug that aims to prevent protein aggregates in the brain and target the treatment of Parkinson's disease. The drug has already been tested in clinical trials and has shown promising results. In addition to PBT434, the company also has other promising drugs in development, including PBT519, targeting the treatment of Alzheimer's disease, and PBT2, targeting the treatment of Huntington's disease. Alterity Therapeutics aims to minimize the impact of neurodegenerative diseases and improve the quality of life for millions of patients worldwide. The company collaborates with leading medical and academic institutions to develop innovative therapeutics that meet the needs of patients and clinicians. Overall, Alterity Therapeutics offers a promising pipeline of drugs that could play a significant role in the treatment of neurodegenerative diseases. The company has become a major player in the industry and has the potential to make a significant impact in the fight against these serious illnesses. Alterity Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Alterity Therapeutics's Liabilities

Alterity Therapeutics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Alterity Therapeutics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Alterity Therapeutics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Alterity Therapeutics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Alterity Therapeutics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Alterity Therapeutics Stock

What is the level of liabilities of Alterity Therapeutics this year?

Alterity Therapeutics has a debt balance of 4.5 M AUD this year.

What were the liabilities of Alterity Therapeutics compared to the previous year?

The liabilities of Alterity Therapeutics have increased by -23.65% dropped compared to the previous year.

What are the consequences of high debt for investors of Alterity Therapeutics?

High liabilities can pose a risk for investors of Alterity Therapeutics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Alterity Therapeutics?

Low liabilities mean that Alterity Therapeutics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Alterity Therapeutics affect the company?

An increase in liabilities of Alterity Therapeutics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Alterity Therapeutics affect the company?

A decrease in the liabilities of Alterity Therapeutics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Alterity Therapeutics?

Some factors that can influence the liabilities of Alterity Therapeutics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Alterity Therapeutics so important for investors?

The liabilities of Alterity Therapeutics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Alterity Therapeutics take to modify the liabilities?

To change its liabilities, Alterity Therapeutics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Alterity Therapeutics pay?

Over the past 12 months, Alterity Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Alterity Therapeutics is expected to pay a dividend of 0 AUD.

What is the dividend yield of Alterity Therapeutics?

The current dividend yield of Alterity Therapeutics is .

When does Alterity Therapeutics pay dividends?

Alterity Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Alterity Therapeutics?

Alterity Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Alterity Therapeutics?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Alterity Therapeutics located?

Alterity Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Alterity Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Alterity Therapeutics from 6/24/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 6/24/2024.

When did Alterity Therapeutics pay the last dividend?

The last dividend was paid out on 6/24/2024.

What was the dividend of Alterity Therapeutics in the year 2023?

In the year 2023, Alterity Therapeutics distributed 0 AUD as dividends.

In which currency does Alterity Therapeutics pay out the dividend?

The dividends of Alterity Therapeutics are distributed in AUD.